Posted on 6/27/18
Is Pfizer's Lead Growth Driver in Trouble?
Ibrance is a small capsule that's been making a big difference during Pfizer Inc.'s (NYSE:PFE)earnings reports since it launched in 2015. Unfortunately, it didn't make a . . .
Posted on 6/27/18
The Children's Hospital at Montefiore Ranks as One of the Best in the Nation
On the just-released list of Best Children's Hospitals in the United States, the Children's Hospital at Montefiore (CHAM) continues to rank as one of the finest . . .
Posted on 6/27/18
CRG's Third Healthcare Fund Closes $204 Million Asset-Backed Securities Financing
CRG, a premier healthcare-focused investment firm, today announced the closing of a $204 million financing on behalf of CRG Partners III, L.P. and certain of its . . .
Posted on 6/26/18
Will Johnson & Johnson's Pipeline Drugs Offset Sales Erosion To Upcoming Generics?
The Pharmaceutical segment represents ~50% of sales and 66% of operating income, and therefore is key to the bull and bear thesis around Johnson and Johnson . . .
Posted on 6/26/18
electroCore Announces Closing of IPO
BASKING RIDGE, N.J., June 26, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq:ECOR) today announced the closing of its initial public offering of 5,200,000 shares of common stock . . .
Posted on 6/26/18
NewYork-Presbyterian Among Nation’s Best in Every Specialty Featured in U.S. News and World Report “Best Children’s Hospitals” Survey
For the 12th year in a row, NewYork-Presbyterian Hospital ranks in more pediatric specialties than any other New York metro area hospital in U.S. News & . . .
Posted on 6/26/18
National Alliance of Healthcare Purchaser Coalitions and Remedy Partners Collaborate
The National Alliance of Healthcare Purchaser Coalitions (National Alliance), a nonprofit network of business coalitions representing more than 12,000 purchasers and 45 million Americans, spending more . . .
Posted on 6/26/18
Johnson & Johnson Offers A Favorable Price For Long-Term Investors
Since peaking in early January, Johnson & Johnson (JNJ) has declined about 18% and now offers long-term investors an opportunity to buy a wide moat, blue-chip, . . .
Posted on 6/26/18
Is PTC Therapeutics Stock a Buy?
PTC Therapeutics (NASDAQ:PTCT) shares went on a roller-coaster ride after the drugmaker unveiled important data -- and so did a competitor. The company is making progress . . .
Posted on 6/25/18
Agadia Systems Announces Agreement with MaxorPlus
Agadia Systems, Inc. (Agadia), an innovator in electronic prior authorization and MTM solutions, and MaxorPlus, a full service PBM pioneering the use of mobile technology to . . .
Posted on 6/25/18
Health Plus Management Acquires AdvancedPMR
Health Plus Management, LLC (Health Plus) is pleased to announce the acquisition of Advanced PMR Management
Posted on 6/25/18
Johnson & Johnson Offers A Favorable Price For Long-Term Investors
Since peaking in early January, Johnson & Johnson (JNJ) has declined about 18% and now offers long-term investors an opportunity to buy a wide moat, blue-chip, . . .
Posted on 6/25/18
Immune Pharmaceuticals And Bertilimumab: A Work In Progress
Investment Analysis:Immune Pharmaceuticals (NASDAQ:IMNP) is a clinical stage biopharmaceutical company focused on the development and commercialization of its lead candidate Bertilimumab, for the treatment of Bullous . . .
Posted on 6/24/18
Joslin Diabetes Center, The American Journal of Managed Care® Collaborate to Publish Clinical Guidelines
CRANBURY, N.J. & BOSTON--(BUSINESS WIRE)--The American Journal of Managed Care®has published core clinical guidelines from Joslin Diabetes Center, the world-renowned center for research, treatment, and education . . .
Posted on 6/24/18
iBio, Inc. Prices $16,000,000 Public Offering
NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) announced the pricing of an underwritten public offering with expected total gross proceeds of approximately . . .
Posted on 6/24/18
Mustang Bio Announces Opening of CAR T Cell Therapy Manufacturing Facility in Worcester, Mass.
NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (NASDAQ:MBIO), a Fortress Biotech (NASDAQ:FBIO) Company focused on the development of novel immunotherapies based on . . .
Posted on 6/24/18
Matinas BioPharma Closes $8.0 Million Public Offering
BEDMINSTER, N.J., June 22, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines . . .
Posted on 6/22/18
electroCore Prices IPO
BASKING RIDGE, N.J., June 21, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) today announced the pricing of its initial public offering of 5,200,000 shares of common . . .
Posted on 6/22/18
AtlantiCare Extends Partnership with Continuum Health
AtlantiCare, a member of Geisinger, has extended its partnership with Continuum Health to provide revenue cycle services for AtlantiCare Physician Group's more than 96 primary and . . .
Posted on 6/21/18
MD Magazine Expands Strategic Alliance Partnership Program
CRANBURY, N.J.--(BUSINESS WIRE)--MD Magazine®, a leading online and print source of physician news, conference coverage and peer-to-peer discussion, adds NYU Langone Health to its Strategic Alliance . . .
Posted on 6/21/18
BeyondSpring Provides Operational Updates
NEW YORK, June 21, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced . . .
Posted on 6/21/18
Johnson & Johnson: Strong Company, But Won't Fit In Most Portfolios
Johnson & Johnson (NYSE:JNJ) is a company with strong financial health and a lot of cash is currently being held for future acquisitions. JNJ is only . . .
Posted on 6/21/18
TripleCare Unveils Telemedicine Services at Two Marquis Health Services Locations
NEW YORK--(BUSINESS WIRE)--TripleCare, a national provider of telemedicine-based healthcare to the post-acute care sector, including skilled nursing facilities (SNFs), announced today its services were recently unveiled . . .
Posted on 6/21/18
Buy Johnson & Johnson
Over the last number of months, bonds have been dropping and yields have been rising. As such, many of the more defensive stocks that trade along . . .
Posted on 6/21/18
Don't Get Too Excited About PTC Therapeutics (Yet)
PTC Therapeutics (NASDAQ:PTCT) shares took off after updated data from a trial evaluating risdiplam suggested it could mount a stiff challenge to Biogen's (NASDAQ:BIIB) and Ionis . . .

